About Genoloam | Our Story


We are facing a healthcare industry that is developing so rapidly and infinitely that it is difficult to define its limitations. In the entire Healthcare system, Prevention, Diagnostics, Treatment, and Cure, various technologies and non-medical fields ranging from biotechnology to information technology and artificial intelligence are being combined. Eventually, the healthcare industry will be transforming into a fusion of all technologies in the world. Therefore, in order to provide better prevention, diagnostics, treatment and care, it is very important to focus on, observe and follow the changes happening in the healthcare industry and find the best combination and solution to quickly apply them to the relevant field. GENOLOAM was founded to become such a specialized company in the new era of healthcare industry.

GENOLOAM is composed of highly skilled experts with years of international experience in various fields related to the new healthcare industry, such as medicine, IT, big data and hardware. Since its foundation, GENOLOAM has established strong partnerships with leading companies specializing in various fields, such as NGS, liquid biopsy, digital-PCR, molecular biotech, biosimilar, deep-learning and artificial intelligence. Based on this preparation process and vision, GENOLOAM has the knowledge to provide comprehensive solutions rather than just products, and further strives to develop into a healthcare convergence group in the era of the 4th industrial revolution.

Our Management | The Passion Behind Genoloam


 

Mr. Wonsang Kim | Lead-in Operation & Product, Co-Founder

Mr. Kim was the CEO and entrepreneurial mind behind TriGem Computer Inc. in South Korea, previously the biggest computer manufacturer in the world, gaining insightful knowledge and valuable contacts in the ICT industry. In 1995, Mr. Kim established RDI Computer Inc. in San Diego, USA, where he and his team developed the world’s first SPARC-based laptop workstation.

During his 20 years in the ICT field, Mr. Kim was responsible for turning grand ideas into deliverable products, projects, and features and over the years, he has expanded his skill set to many other fields, including IT, genome, diagnosis & healthcare, etc. Since 2018, Mr. Kim has worked as the President of K-Challenge Inc., an international consulting company in South Korea, where he devotes himself to the establishment of close economic relations between Korea and the Baltic States.

LinkedIn

 
Dr. Tommi Vaskivuo Genoloam

Dr. Tommi Vaskivuo | Lead-in Medicine & Consulting, Co-Founder

Since joining Genoloam, Dr. Vaskivuo has played a crucial role to strive its success. Dr. Vaskivuo has a successful track record in Pan-European bio-pharma and diagnostic business. In his latest position as the Chief Medical Officer for Europe’s largest diagnostic service provider, he has negotiated and executed several government contracts on COVID19 testing solutions. Dr. Vaskivuo’s key trademark is the Innovative and straightforward solutions to complex and challenging problems.

LinkedIn

 
Suk-Jae Chang Genoloam

Mr. Suk-Jae Chang | Lead-in Strategy & IT, Founder

Mr. Chang is an essential part of our team, and has been with Genoloam since the very beginning. As an international serial entrepreneur, Mr. Chang has established and led companies in the fields of Multimedia Kiosk, System Integration, Stock Market Information, Mobile Game and Diagnosis & Healthcare in South Korea, Japan, the United States, Estonia and Finland. In addition, Mr. Chang has been the advisor to various central & local governments and companies and has an extensive network of top leaders in the government, politics, and business sectors in Korea and the countries above.

Currently, Mr. Chang has officially been appointed by the Korean and Estonian governments as the Honorary Consul General of The Republic of Estonia in South Korea and is actively performing his duty for both nations. Mr. Chang had his teaching career as an adjunct professor at Parsons School of Design and Harvard University in the States and has received the presidential citation from Kim Daejoong, former President of Korea.

LinkedIn